Onpattro (Patisiran)

Onpattro (Patisiran)

Onpattro

Patisiran

Lipid Complex Injection: 10 mg/5 mL (2 mg/mL) in a single-dose vial

Alnylam Pharmaceuticals, Inc.

Medical Use

Onpattro contains a small interfering RNA that targets transthyretin and is used to treat polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis.

Recommended Dosage: Onpattro is available as a liquid in a single-dose vial and must be administered by a healthcare professional via intravenous (IV) infusion. The dosage depends on the patient’s body weight.

  • For patients under 100 kg, the recommended dose is 0.3 mg/kg every 3 weeks.
  • For patients 100 kg or more, the recommended dose is 30 mg every 3 weeks.

Missed Dose: If a dose is missed, it should be administered as soon as possible.

  • If administered within 3 days of the missed dose, continue with the original schedule.
  • If more than 3 days have passed, continue dosing every 3 weeks from the new administration date.